We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
1751
Permian Basin Royalty Trust
PBT
$1.36B
$92K ﹤0.01%
15,181
+1,000
+7% +$6.43K
BGC icon
1752
BGC Group
BGC
$5.58B
$88K ﹤0.01%
16,809
-9,000
-35% -$46.7K
DSE
1753
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$88K ﹤0.01%
1,800
VHI icon
1754
Valhi
VHI
$385M
$86K ﹤0.01%
2,404
ENDP
1755
DELISTED
Endo International plc
ENDP
$85K ﹤0.01%
+20,529
New +$130K
GLUU
1756
DELISTED
Glu Mobile Inc.
GLUU
$84K ﹤0.01%
11,650
+1,500
+15% +$13.8K
BNBX
1757
DELISTED
BNB PLUS CORP
BNBX
0
MCR
1758
DELISTED
MFS Charter Income Trust
MCR
$83K ﹤0.01%
+10,139
New +$80.7K
AKBA icon
1759
Akebia Therapeutics
AKBA
$327M
$82K ﹤0.01%
17,036
-307
-2% -$1.75K
ELMD icon
1760
Electromed
ELMD
$318M
$82K ﹤0.01%
15,000
BCIC
1761
BCP Investment Corp
BCIC
$86.9M
$82K ﹤0.01%
3,627
+140
+4% +$3.94K
SNAP icon
1762
CALL
Snap
SNAP
$7.32B
$81K ﹤0.01%
101,300
+1,300
+1% +$15.9K
SVM
1763
Silvercorp Metals
SVM
$2.13B
$81K ﹤0.01%
32,858
PDLI
1764
DELISTED
PDL BioPharma, Inc.
PDLI
$81K ﹤0.01%
25,800
-1,100
-4% -$3.57K
MFM
1765
Aberdeen Municipal Income Fund
MFM
$222M
$80K ﹤0.01%
11,467
MA icon
1766
CALL
Mastercard
MA
$477B
$79K ﹤0.01%
1,000
HDSN
1767
Hudson Technologies
HDSN
$267M
$77K ﹤0.01%
89,450
BYND icon
1768
PUT
Beyond Meat
BYND
$288M
$76K ﹤0.01%
+2,000
New +$223K
JNJ icon
1769
PUT
Johnson & Johnson
JNJ
$634B
$75K ﹤0.01%
+27,300
New +$3.78M
OBE
1770
Obsidian Energy
OBE
$707M
$75K ﹤0.01%
63,046
+15,620
+33% +$28.2K
GNW icon
1771
Genworth Financial
GNW
$3.8B
$74K ﹤0.01%
20,011
-5,621
-22% -$19.9K
BNED icon
1772
Barnes & Noble Education
BNED
$412M
$73K ﹤0.01%
+216
New +$83K
ABEV icon
1773
Ambev
ABEV
$47.3B
$72K ﹤0.01%
15,312
+158
+1% +$708
FBRX icon
1774
Forte Biosciences
FBRX
$1.12B
$72K ﹤0.01%
29
PPT
1775
Franklin Premier Income Trust
PPT
$323M
$72K ﹤0.01%
13,943
-11,851
-46% -$60.9K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.